We are live on ! Find out more
LOIM

Liberty One Investment Management Portfolio holdings

AUM $970M
1-Year Est. Return 12.15%
This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+12.15%
3 Year Est. Return
+38.77%
5 Year Est. Return
+56.87%
10 Year Est. Return
AUM
$489M
AUM Growth
+$42.6M
Cap. Flow
+$17.3M
Cap. Flow %
3.53%
Top 10 Hldgs %
36.5%
Holding
136
New
1
Increased
97
Reduced
37
Closed
1

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$1.36M
2
SO icon
Southern Company
SO
+$1.17M
3
DUK icon
Duke Energy
DUK
+$1M
4
MMM icon
3M
MMM
+$988K
5
KO icon
Coca-Cola
KO
+$930K

Top Sells

Rank Stock Value
1
RUN icon
Sunrun
RUN
+$1.18M
2
SAM icon
Boston Beer
SAM
+$374K
3
AAPL icon
Apple
AAPL
+$340K
4
AMZN icon
Amazon
AMZN
+$186K
5
CLX icon
Clorox
CLX
+$183K

Sector Composition

Rank Sector Weight
1 Consumer Staples 37.37%
2 Healthcare 14.91%
3 Utilities 12.03%
4 Industrials 11.05%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRVB
126
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$71K 0.01%
5,532
+2,714
+96% +$34.3K
DRI icon
127
Darden Restaurants
DRI
$25.9B
$61K 0.01%
609
+269
+79% +$22.3K
AYX
128
DELISTED
Alteryx Inc
AYX
$61K 0.01%
535
+252
+89% +$34.3K
CHWY icon
129
Chewy
CHWY
$9.15B
$55K 0.01%
1,012
+416
+70% +$22.4K
MDGL icon
130
Madrigal Pharmaceuticals
MDGL
$12.4B
$52K 0.01%
435
+206
+90% +$22.4K
MTZ icon
131
MasTec
MTZ
$22.6B
$50K 0.01%
1,177
+510
+76% +$21.9K
CFG icon
132
Citizens Financial Group
CFG
$31.1B
$47K 0.01%
1,839
+895
+95% +$22.7K
KRYS icon
133
Krystal Biotech
KRYS
$9.85B
$45K 0.01%
1,037
+527
+103% +$22.9K
ITCI
134
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$44K 0.01%
+1,727
New +$39.4K
WW
135
DELISTED
WW International
WW
$37K 0.01%
1,971
+932
+90% +$21.9K
ICPT
136
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-329
Closed -$16K

Similar funds

Liberty One Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Liberty One Investment Management held 136 positions worth $489M, up 9.6% from $446M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Liberty One Investment Management deployed $17.3M of net new capital in Q3 2020, opening 1 new position and adding to 97 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 1,727 shares worth $44K.

By sector, the portfolio is most concentrated in Consumer Staples at 37% of assets, down from 38% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Sunrun, an estimated $1.18M trimmed.

  • Liberty One Investment Management's largest Q3 2020 buy was Intra-Cellular Therapies Inc.: 1,727 shares worth $44K.
  • Liberty One Investment Management added most to AT&T in Q3 2020, an estimated $1.36M increase.
  • Liberty One Investment Management's biggest Q3 2020 reduction was Sunrun, cutting an estimated $1.18M.
  • Liberty One Investment Management fully exited Intercept Pharmaceuticals, Inc. in Q3 2020, selling an estimated $16K.
  • Liberty One Investment Management's ten largest holdings make up 36% of its $489M portfolio in Q3 2020.
  • Liberty One Investment Management opened 1 new position and closed 1 in Q3 2020.
  • Liberty One Investment Management's portfolio value rose 9.6% quarter-over-quarter to $489M.

Based on Liberty One Investment Management's 13F filing for Q3 2020, filed 3 Nov 2020.